The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, partners can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.
The CVSN Council accelerates the discovery, interpretation, and application of science to enhance cardiovascular health and treat cardiovascular diseases and stroke. The council helps develop scientific statements and advisories, guide professional education activities, provide scientific expertise, conduct research, translate findings, and promote evidence-based practices in clinical settings.
TAVR Low Risk Bicuspid Study | Basel Ramlawi, MD
Co-Principal Investigator Basel Ramlawi, MD summarizes the results of the TAVR Low Risk Bicuspid Study which he presented virtually for ACC 2020. The prospective single-arm interventional study examined TAVR for patients with severe aortic stenosis. See this study and other late-breaking science presentations on our AHA Science News from ACC 2020 page.